Company Monitoring Page for Merck

latest headlines for company on cafepharma

Reworking the Broken R&D Model
Motley Fool
Wed, 04/22/09 - 07:13 am
Tags:
R&D, GSK, Merck, Isis Pharmaceuticals, Alnylam, Bristol-Myers Squibb, Gilead Sciences, Pfizer, Alkermes, Amylin
Schering and Merck: A Match Made in Purgatory
Motley Fool
Wed, 04/22/09 - 07:11 am
Tags:
Merck, Schering Plough, earnings, buyouts
Merck's Transaminases Transgression
CNBC
Wed, 04/22/09 - 07:10 am
Tags:
Merck, earnings, FDA, migraines
FDA, Clinical Trial Calendar Updates: Actelion, Merck Discontinue Partnership
Seeking Alpha
Tue, 04/21/09 - 09:17 am
Tags:
FDA, drug trials, Merck, Dendreon, Actelion, Forest Labs, Cypress Bioscience, Cell Therapeutics
Merck Profit Falls, Misses Expectations
CNBC
Tue, 04/21/09 - 07:44 am
Tags:
Merck, earnings
Merck to license infection drug for up to $225 million
Marketwatch
Tue, 04/21/09 - 06:53 am
Tags:
Merck, anti-infectives, licensing, Medarex
Earnings Preview: Merck
Seeking Alpha
Mon, 04/20/09 - 04:28 pm
Tags:
Merck, earnings
Galapagos signs Merck deal, shares leap
Reuters
Mon, 04/20/09 - 10:40 am
Tags:
Galapagos, Merck
Drugmaker Schering-Plough awaits acquisition by Merck, FDA ruling on psychiatric medicine
Yahoo/AP
Fri, 04/17/09 - 06:15 pm
Tags:
Merck, earnings, Schering Plough, buyouts, FDA, Saphris, bipolar disorder, schizophrenia
Merck, Biogen Boost Lobbying to Defy Obama’s Drug Comparisons
Bloomberg
Fri, 04/17/09 - 06:08 am
Tags:
Obama, Merck, Biogen Idec, lobbying
Vermont doctors get $2.9M cash, gifts from drugmakers
Yahoo/AP
Thu, 04/16/09 - 08:36 am
Tags:
Pfizer, Merck, Eli Lilly, physician payments
Merck Exec on R&D: ‘Nothing Is Safe From Cuts’
WSJ Online
Wed, 04/15/09 - 10:00 am
Tags:
Merck, R&D
Merck licenses Santen eye drug for undisclosed sum
Yahoo/AP
Wed, 04/15/09 - 08:58 am
Tags:
Merck, licensing, Santen, tafluprost
Bristol-Myers on the Prowl for Deals – BMY, PFE, MRK, AZN
Stock Traders Daily
Tue, 04/14/09 - 10:04 am
Tags:
Bristol-Myers Squibb, Pfizer, Merck, Wyeth, Schering Plough, AstraZeneca, Exelixis
Cardiome May See More Upside When IV Formulation Gets Clarified - RBC
Seeking Alpha
Tue, 04/14/09 - 06:23 am
Tags:
Cardiome, Merck, atrial fibrillation
Defensive pharma promises solid Q1 results
Yahoo/Reuters
Mon, 04/13/09 - 09:14 am
Tags:
Abbott Laboratories, JNJ, Merck
Former Merck Rep Runs Program to Detail Docs on Public Health
WSJ Online
Mon, 04/13/09 - 09:13 am
Tags:
Merck, New York, sales reps
IHE: Large-Cap Pharma Continues to Blow Away the S&P 500
Seeking Alpha
Mon, 04/13/09 - 08:48 am
Tags:
JNJ, Merck, Pfizer, Schering Plough
Merck Deal Cushions Cardiome From Financial, Regulatory Turmoil...
InVivo
Fri, 04/10/09 - 09:18 am
Tags:
Merck, Cardiome
Being Second In Line No Hurdle In Pharma
Yahoo/Investors Business Daily
Fri, 04/10/09 - 08:29 am
Tags:
diabetes, Bristol-Myers Squibb, AstraZeneca, Onglyza, Merck, Januvia

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.